Integrated Investment Consultants LLC purchased a new stake in shares of McKesson Co. (NYSE:MCK – Get Rating) during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 591 shares of the company’s stock, valued at approximately $201,000.
A number of other hedge funds have also recently made changes to their positions in MCK. WCM Investment Management LLC acquired a new stake in shares of McKesson during the third quarter valued at about $302,630,000. Artisan Partners Limited Partnership acquired a new stake in shares of McKesson during the second quarter valued at about $144,978,000. Arrowstreet Capital Limited Partnership raised its position in shares of McKesson by 53.8% during the first quarter. Arrowstreet Capital Limited Partnership now owns 915,949 shares of the company’s stock worth $280,399,000 after acquiring an additional 320,588 shares during the last quarter. Canada Pension Plan Investment Board raised its position in shares of McKesson by 7,667.1% during the third quarter. Canada Pension Plan Investment Board now owns 230,062 shares of the company’s stock worth $78,191,000 after acquiring an additional 227,100 shares during the last quarter. Finally, Great West Life Assurance Co. Can bought a new position in shares of McKesson during the third quarter worth about $73,045,000. 85.23% of the stock is owned by institutional investors and hedge funds.
McKesson Stock Down 0.3 %
NYSE MCK opened at $335.35 on Thursday. The company has a market cap of $45.92 billion, a price-to-earnings ratio of 15.33, a P/E/G ratio of 1.25 and a beta of 0.59. McKesson Co. has a 52 week low of $287.14 and a 52 week high of $401.78. The business has a 50 day moving average price of $364.48 and a 200-day moving average price of $366.74.
McKesson Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Monday, April 3rd. Investors of record on Wednesday, March 1st will be given a dividend of $0.54 per share. The ex-dividend date is Tuesday, February 28th. This represents a $2.16 annualized dividend and a dividend yield of 0.64%. McKesson’s payout ratio is 9.88%.
Insider Activity at McKesson
In related news, EVP Nancy Avila sold 161 shares of McKesson stock in a transaction that occurred on Friday, February 3rd. The stock was sold at an average price of $370.02, for a total transaction of $59,573.22. Following the transaction, the executive vice president now owns 4,631 shares of the company’s stock, valued at $1,713,562.62. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. In other McKesson news, CEO Brian S. Tyler sold 7,416 shares of the business’s stock in a transaction on Thursday, February 2nd. The stock was sold at an average price of $380.00, for a total value of $2,818,080.00. Following the transaction, the chief executive officer now owns 75,737 shares of the company’s stock, valued at $28,780,060. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, EVP Nancy Avila sold 161 shares of the business’s stock in a transaction on Friday, February 3rd. The stock was sold at an average price of $370.02, for a total value of $59,573.22. Following the completion of the transaction, the executive vice president now directly owns 4,631 shares in the company, valued at approximately $1,713,562.62. The disclosure for this sale can be found here. 0.21% of the stock is owned by insiders.
Wall Street Analysts Forecast Growth
MCK has been the subject of a number of analyst reports. UBS Group lowered their price objective on McKesson from $450.00 to $440.00 and set a “buy” rating for the company in a research report on Tuesday, January 31st. Morgan Stanley raised their price objective on McKesson from $420.00 to $426.00 and gave the stock an “overweight” rating in a research report on Thursday, February 2nd. StockNews.com started coverage on McKesson in a research report on Thursday. They set a “strong-buy” rating for the company. Finally, Robert W. Baird lifted their target price on McKesson from $445.00 to $450.00 and gave the stock an “outperform” rating in a report on Thursday, February 2nd. Two analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $416.30.
About McKesson
McKesson Corp. engages in the provision of supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology. It operates through the following segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS).
Further Reading
- Get a free copy of the StockNews.com research report on McKesson (MCK)
- Meta Platforms: Efficiency Gains Momentum, Stock Accelerates
- Pfizer’s Latest Acquisition Strengthens the Case for PFE Stock
- SentinelOne: Reversal In-Play For Cybersecurity Stocks
- Is Sportradar Group A Growth Stock To Bet On In 2023?
- Strong Guidance says Boeing is Ready for Takeoff
Want to see what other hedge funds are holding MCK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McKesson Co. (NYSE:MCK – Get Rating).
Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.